Arrowhead has not initiated research coverage on Nicox S.A. yet.

About
Nicox is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. Their strategy is to become a fully integrated pharmaceutical company focused on the discovery, development and commercialization of novel ophthalmic therapeutics for eye...
Nicox is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. Their strategy is to become a fully integrated pharmaceutical company focused on the discovery, development and commercialization of novel ophthalmic therapeutics for eye diseases. This strategy includes advancing Nicox's product candidates through clinical development to approvals in the U.S., optimizing the development through partnerships, maximizing the value of our product ZERVIATE through collaborations and expanding their product candidate pipeline through internal research efforts and potential in-licensing activities or acquisitions of additional ophthalmic product candidates or products.

Executive Management :

Mr. Michele Garufi ( Chairman and Chief Executive Officer )
Mrs. Sandrine Gestin ( Vice President, Finances )
Mrs. Emmanuelle Pierry ( General Counsel & Head of Legal )
Mr. Gavin Spencer ( Executive Vice-President, Chief Business Officer & Head of Corporate Development )
Mr. José Boyer ( Interim Head of R&D )

Board of Directors :

Mr. Michele Garufi ( Chairman and Chief Executive Officer )
Mrs. Adrienne Graves ( Former President and Chief Executive Officer of Santen Inc. )
Mr. Les Kaplan ( Former Executive Chairman of Aciex Therapeutics, Inc. )
Mr. Luzi Von Bidder ( Former Chairman of Acino Holding AG )
Mr. Jean-François Labbe ( Chief Executive Officer, SpePharm Holding BV )
Mrs. Lauren Silvernail ( Chief Financial Officer and Executive Vice President, Corporate Development of Evolus, Inc. )